Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 845.41 million compared to CNY 538.78 million a year ago. Revenue was CNY 846.35 million compared to CNY 540.17 million a year ago.

Net income was CNY 135.29 million compared to CNY 82.78 million a year ago. Basic earnings per share from continuing operations was CNY 0.1293 compared to CNY 0.0791 a year ago. Diluted earnings per share from continuing operations was CNY 0.1293 compared to CNY 0.0791 a year ago.